Statistics

Total Visits

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program80

Select a period of time:

Number of views in the range

Views
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program32

Views

Views
April 20252
May 20257
June 20252
July 202518
August 20250
September 20253
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil8
Spain5
Hong Kong2
Colombia1
Germany1
Egypt1
United Kingdom1
Turkey1
Uruguay1
 

Top cities views

Views
Madrid3
Hong Kong2
Cairo1
Capelinha1
Caxias1
Cerro Grande do Sul1
Council Bluffs1
Florianópolis1
Gary1
Goiânia1